Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP10 leads to the deubiquitination of mutated FLT3. 2 / 2

| 2

➶

reach

"In addition to mutant FLT3–ITD, another spleen tyrosine kinase (SYK), a critical regulator of FLT3, was deubiquitinated and stabilized by USP10; depleting or inhibiting USP10 reduced the expression of SYK, which promoted the proliferation of Ba/F3 and MOLM14 cells [68,84]."

35627217

➶

reach

"Given our recent finding that USP10 deubiquitinates mutant FLT3, 18 coupled with reported studies showing that FLT3 and SYK are interacting partners with each other and are targets of the same E3 ligase c-CBL, XREF_BIBR, XREF_BIBR, XREF_BIBR - XREF_BIBR we hypothesised that USP10 may play a role in stabilisation of SYK."

32015510

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...